Dr. JenniferTsai

Top bone marrow transplant specialist specializing in leukemia, lymphoma and myelodysplastic syndrome (MDS).

About

Dr. Jennifer Tsai, MD, PhD, is a bone marrow transplant specialist dedicated to the diagnosis and treatment of blood cancers. She sees patients at Memorial Hospital in New York City, where she provides expert care for individuals with leukemia, lymphoma, multiple myeloma, and myelodysplastic syndrome (MDS). Her dual training as both a physician and researcher reflects a commitment to bringing rigorous scientific knowledge to the care of patients with complex hematologic malignancies.

Why they are a top doctor

Research papers · PubMed

101

Published, peer-reviewed work, the clearest public measure of expertise in a specialty.

Cited by other doctors

3.6k

How often other doctors and researchers build on their work.

Known for

Bone marrow transplant

The distinction that sets them apart from other bone marrow transplant specialists.

Background

Education

Medical school: MD, University of Otago, New Zealand · PhD, Weill Cornell Graduate School of Medical Sciences

Residency: Internal Medicine, State University of New York, Downstate Medical Center

Fellowship: Medical Oncology, Memorial Sloan Kettering Cancer Center

Awards

KL2 Scholar Award, Weill Cornell Medicine Clinical & Translational Science Center (2024)

Leukemia Career Enhancement Program Awards, Memorial Sloan Kettering Specialized Program of Research Excellence (SPORE) (2024)

New Investigator Award, American Society for Transplantation and Cellular Therapy (2024)

Mortimer J. Lacher Fellowship, Memorial Sloan Kettering Cancer Center (2024)

Research Training Award for Fellows, American Society of Hematology (2023)

Conquer Cancer Young Investigator Award, American Society of Clinical Oncology (2023)

Women Physicians Inspiration Award, American Medical Association (2022)

Trials for leukemia

All trials ›

Recruiting · Phase 3 · Interventional

Measuring the Effects of New Treatment for Young Adults with Leukemia

B Acute Lymphoblastic Leukemia · Across 40 states

Adult · All sexes · NCT03150693

Recruiting · Phase 3 · Interventional

Adding Inotuzumab Ozogamicin to Standard Treatment for High-Risk Blood Cancers

B Acute Lymphoblastic Leukemia · Across 49 states

Child, Adult · All sexes · NCT03959085

Recruiting · Phase 3 · Interventional

Checking Early Treatment Options for Patients with High-Risk CLL or SLL

Chronic Lymphocytic Leukemia · Across 43 states

Adult, Older adult · All sexes · NCT04269902

Similar specialists

Dr. Ann A. Jakubowski

Hematologist-Oncologist · New York, NY

Leukemia · Acute myeloid leukemia (AML) · Chronic lymphocytic leukemia (CLL / SLL) · Chronic myeloid leukemia (CML) · Myelodysplastic syndrome (MDS) · Myeloproliferative neoplasms (PV, ET, myelofibrosis)

Dr. Esperanza B. Papadopoulos

Hematologist-Oncologist · New York, NY

Bone marrow failure syndromes (not cancer) · Myelodysplastic syndrome (MDS) · Lymphoma · Acute myeloid leukemia (AML) · Chronic lymphocytic leukemia (CLL / SLL) · Non-Hodgkin lymphoma (NHL) · Post-transplant lymphoproliferative disorder (PTLD)

Dr. Katharine C. Hsu

Hematologist-Oncologist · New York, NY

Leukemia · Lymphoma

Cancerify

Ask Cancerify